Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
74.85
+4.13 (5.84%)
At close: Oct 8, 2025, 4:00 PM EDT
77.00
+2.15 (2.87%)
After-hours: Oct 8, 2025, 6:38 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $827.82 million as of October 8, 2025.
Market Cap
827.82M
Enterprise Value
771.89M
1-Year Change
n/a
Ranking
Category
Stock Price
$74.85
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $827.82M, an increase of 474.99%. That is a compound annual growth rate of 770.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 782.14M | 480.84% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |